‘Ozempic Santa’: Musk Reveals His Use Of Mounjaro In Latest Weight-Loss Drug Endorsement
Tesla chief Elon Musk dubbed himself “Ozempic Santa” in an X post on Christmas Day, marking the tech billionaire’s latest show of support for weight-loss drugs as he has pushed for making them more accessible to the general public.
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.
Elon Musk admits he takes the Ozempic-like weight loss drug that RFK Jr. wants to restrict
This holiday season, Elon Musk is calling himself “Ozempic Santa.” Adorned in a Santa Suit on a photo posted to X, The Tesla founder indicates he’s taking one of the widely popular weight loss drugs,
Elon Musk Reveals He Lost Weight While Taking Mounjaro
Elon Musk posted a photo with the caption "Ozempic Santa" and revealed that he's taking Mounjaro for weight loss. Musk, who Donald Trump appointed to advise him on cutting government spending, has struggled with his weight.
Tesla CEO Elon Musk Poses As 'Ozempic Santa' On X, Revealing Use Of Popular Weight Loss Drug
Elon Musk recently shared a post on X, revealing he uses the weight loss drug Mounjaro. Musk posed in a Santa Claus outfit by a holiday tree and captioned the post, "Ozempic Santa," later clarifying he uses Mounjaro.
Elon Musk calls himself 'Ozempic Santa' after upgrading to powerful 'King Kong' of weight-loss drugs
Elon Musk has revealed he has switched to a more powerful weight-loss drug, sharing the news alongside a photo of himself dressed as Father Christmas. The SpaceX billionaire, 53, posted a picture of himself slimmed down in a red-and-white fur-lined suit with the caption: "Ozempic Santa".
Eli Lilly to end 2024 among best in Big Pharma; Novo among worst
As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...
Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod
Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...
Does This News From the FDA Make Eli Lilly a Buy for 2025?
In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...
Eli Lilly and Company (NYSE:LLY) Trading Down 0.2% – What’s Next?
Eli Lilly and Company (NYSE:LLY – Get Free Report) was down 0.2% on Thursday . The company traded as low as $791.50 and last ...
NBC 10 Philadelphia7d
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tirzepatide, the active ingredient in Zepbound, has been sold on the U.S. market for longer as the diabetes drug Mounjaro.
Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength.
The obesity drug race is heating up in more ways than one.Eli Lilly, the world’s biggest pharmaceutical company by market ...
Eli Lilly: A Rare Buying Opportunity
Eli Lilly's key products, Mounjaro and Zepbound, dominate the U.S. weight loss market. Read more to see why I rate LLY stock ...
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...